Overview

Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
While statin treatment may induce plaque regression, the effect of statin on plaque composition with varying doses is unknown. This study assessed such effects by volumetric virtual histology intravascular ultrasound (VH-IVUS). In this prospective, randomized, double-blinded pilot study, statin-naïve patients with stable angina requiring percutaneous coronary intervention (PCI) were randomized to receive 6 months of either atorvastatin 10mg or 40 mg daily. VH-IVUS was performed in all non-PCI lesions at baseline and 6 months; all analyses were performed by core laboratory.
Phase:
Phase 4
Details
Lead Sponsor:
Prof. Stephen Lee
Collaborators:
Pfizer
Queen Mary Hospital, Hong Kong
Treatments:
Atorvastatin
Atorvastatin Calcium